Skip to content

LAB 06: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LAB 06

BE 1003.651.872
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€20,077
2024 · €45,031-€65,108
Equity
€34,955
2024 · €55,031-€20,077
Cash
€43,419
2024 · €33,615+€9,804
Balance sheet total
€1.3m
2024 · €1.2m+€131,742

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€199,871

    up €199,871 (+96.3%), from €207,629 to €407,500

    of which Other amounts receivable: +€150,031

  • Intangible fixed assets -€53,700

    down €53,700 (-11.1%), from €483,300 to €429,600

  • Tangible fixed assets -€39,244

    down €39,244 (-25.2%), from €155,975 to €116,731

  • Stocks and contracts +€14,036

    up €14,036 (+6.3%), from €221,399 to €235,435

Equity and liabilities
  • Trade debts +€208,422

    up €208,422 (+87.1%), from €239,286 to €447,708

  • Other debts -€118,027

    down €118,027 (-72.9%), from €161,880 to €43,853

  • Current portion of long-term debt +€49,540

    up €49,540 (+104%), from €47,567 to €97,108

  • Profit (loss) carried forward -€20,077

    down €20,077 (-44.6%), from €45,031 to €24,955

Income statement
  • Gross operating margin -€51,928

    down €51,928 (-15.1%), from €342,929 to €291,001

  • Financial charges +€25,440

    up €25,440 (+67.3%), from €37,791 to €63,231

  • Taxes -€15,816

    no longer reported in 2025 (was €15,816)

  • Staff costs +€5,076

    up €5,076 (+3.4%), from €148,870 to €153,947

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €45,031
Gross operating margin -€51,928
Staff costs -€5,076
Depreciation +€633
Other operating charges +€857
Financial income +€30
Financial charges -€25,440
Taxes +€15,816
Result 2025 -€20,077
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€49,260
Investment €0
Financing +€59,064
Cash 2024 €33,615
Net result for the year -€20,077
Depreciation +€92,944
Stocks and contracts -€14,036
Receivables within one year -€199,871
Deferred charges and accrued income -€974
Trade debts +€208,422
Tax, wage and social debts -€5,309
Advances received +€6,582
Other debts -€118,027
Accrued charges and deferred income +€1,086
Debts after one year +€9,524
Current portion of long-term debt +€49,540
Cash 2025 €43,419
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,176,570 €1,308,312 +€131,742 +11.2%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €639,638 €546,694 -€92,944 -14.5%
Intangible fixed assets 21 €483,300 €429,600 -€53,700 -11.1%
Tangible fixed assets 22/27 €155,975 €116,731 -€39,244 -25.2%
Furniture and vehicles 24 €155,975 €116,731 -€39,244 -25.2%
Financial fixed assets 28 €363 €363 = 0.0%
Current assets 29/58 €536,932 €761,618 +€224,686 +41.8%
Stocks and contracts in progress 3 €221,399 €235,435 +€14,036 +6.3%
Stocks 30/36 €221,399 €235,435 +€14,036 +6.3%
Amounts receivable within one year 40/41 €207,629 €407,500 +€199,871 +96.3%
Trade receivables 40 €33,800 €83,640 +€49,840 +147%
Other amounts receivable 41 €173,829 €323,860 +€150,031 +86.3%
Cash at bank and in hand 54/58 €33,615 €43,419 +€9,804 +29.2%
Deferred charges and accrued income 490/1 €74,289 €75,263 +€974 +1.3%
Total equity and liabilities 10/49 €1,176,570 €1,308,312 +€131,742 +11.2%
Equity 10/15 €55,031 €34,955 -€20,077 -36.5%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €45,031 €24,955 -€20,077 -44.6%
Amounts payable 17/49 €1,121,538 €1,273,357 +€151,819 +13.5%
Amounts payable after more than one year 17 €603,465 €612,989 +€9,524 +1.6%
Financial debts 170/4 €603,465 €612,989 +€9,524 +1.6%
Amounts payable within one year 42/48 €518,073 €659,282 +€141,209 +27.3%
Current portion of amounts payable after more than one year 42 €47,567 €97,108 +€49,540 +104%
Trade debts 44 €239,286 €447,708 +€208,422 +87.1%
Suppliers 440/4 €239,286 €447,708 +€208,422 +87.1%
Advances received on contracts in progress 46 €20,000 €26,582 +€6,582 +32.9%
Taxes, remuneration and social security 45 €49,340 €44,031 -€5,309 -10.8%
Taxes 450/3 €27,684 €25,013 -€2,672 -9.6%
Remuneration and social security 454/9 €21,656 €19,018 -€2,637 -12.2%
Other amounts payable 47/48 €161,880 €43,853 -€118,027 -72.9%
Accrued charges and deferred income 492/3 - €1,086 +€1,086
Remuneration, social security and pensions 62 €148,870 €153,947 +€5,076 +3.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €93,577 €92,944 -€633 -0.7%
Other operating charges 640/8 €1,856 €998 -€857 -46.2%
Gross operating margin 9900 €342,929 €291,001 -€51,928 -15.1%
Operating profit (loss) 9901 €98,626 €43,112 -€55,514 -56.3%
Financial income 75/76B €12 €42 +€30 +249%
Recurring financial income 75 €12 €42 +€30 +249%
Financial charges 65/66B €37,791 €63,231 +€25,440 +67.3%
Recurring financial charges 65 €37,791 €63,231 +€25,440 +67.3%
Profit (loss) for the period before taxes 9903 €60,847 -€20,077 -€80,924
Income taxes 67/77 €15,816 - -€15,816
Profit (loss) for the period 9904 €45,031 -€20,077 -€65,108
Profit (loss) for the period to be appropriated 9905 €45,031 -€20,077 -€65,108

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.